Mettrum
Mettrum Ltd. is a Health Canada licensed agri-pharmaceutical company committed to ongoing research, regulatory compliance, defining and incorporating industry best practices throughout our production processes, and fast and reliable distribution of medical marijuana.
Cinaport, through its related Cinaport Acquisition Corp. (CPQ.H: TSX-V) (the “Company”), a capital pool company listed on the NEX board of the TSX Venture Exchange (the “Exchange”), entered into a binding letter of intent (the “LOI”) on June 18, 2014 with Mettrum Ltd. The LOI outlines the principal terms and conditions pursuant to which the Company and Mettrum intend to complete a transaction that will result in a reverse takeover of the Company by the shareholders of Mettrum. The transaction will constitute the Company’s Qualifying Transaction (the “Qualifying Transaction”) under the policies of the Exchange.
Cinaport, through its related Cinaport Acquisition Corp. (CPQ.H: TSX-V) (the “Company”), a capital pool company listed on the NEX board of the TSX Venture Exchange (the “Exchange”), entered into a binding letter of intent (the “LOI”) on June 18, 2014 with Mettrum Ltd. The LOI outlines the principal terms and conditions pursuant to which the Company and Mettrum intend to complete a transaction that will result in a reverse takeover of the Company by the shareholders of Mettrum. The transaction will constitute the Company’s Qualifying Transaction (the “Qualifying Transaction”) under the policies of the Exchange.